Krka dd 2024 AR2
The report highlights Krka Group's record-breaking financial performance in 2024, generating €1,909.5 million in sales revenue and a net profit of €356.2 million. The company manufactured and packed a record 18.9 billion tablets and capsules, expanding its production capacities across multiple sites. Krka also advanced its sustainability practices, scoring 56 out of 100 in the S&P Global Corporate Sustainability Assessment, placing it in the top 10% of the pharmaceutical industry. Key strategic milestones included the establishment of a joint venture in India, Krka Pharma Pvt. Ltd., and the completion of the Paviljon 3 multi-purpose building in Slovenia.
Company: Krka dd
Sector: Health Care
Country: Slovenia
Year: 2024
Type: AR2
Pages: 394
Krka dd
Annual Report
The report highlights Krka Group's record-breaking financial performance in 2024, generating €1,909.5 million in sales revenue and a net profit of €356.2 million. The company manufactured and packed a record 18.9 billion tablets and capsules, expanding its production capacities across multiple sites. Krka also advanced its sustainability practices, scoring 56 out of 100 in the S&P Global Corporate Sustainability Assessment, placing it in the top 10% of the pharmaceutical industry. Key strategic milestones included the establishment of a joint venture in India, Krka Pharma Pvt. Ltd., and the completion of the Paviljon 3 multi-purpose building in Slovenia.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees